Werewolf Therapeutics, Inc. (HOWL) — Cash & Equivalents
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $57.05M | -48.6% |
| 2024 | $111.00M | -17.4% |
| 2023 | $134.34M | +3.9% |
| 2022 | $129.31M | -17.9% |
| 2021 | $157.53M | +70.2% |
| 2020 | $92.57M | — |
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $57.05M | -48.6% |
| 2024 | $111.00M | -17.4% |
| 2023 | $134.34M | +3.9% |
| 2022 | $129.31M | -17.9% |
| 2021 | $157.53M | +70.2% |
| 2020 | $92.57M | — |